Wallington Asset Management LLC Increases Position in Amgen Inc. (NASDAQ:AMGN)

Henrietta Strickland
September 12, 2017

N+1 Singer reiterated a buy rating and issued a GBX 690 ($8.62) target price on shares of Bodycote PLC in a research note on Friday, November 18th. The stock has a market cap of $136.91 billion, a PE ratio of 17.09 and a beta of 1.35. Swiss National Bank now owns 2,636,008 shares of the medical research company's stock valued at $432,490,000 after buying an additional 551,600 shares in the last quarter. The company saw 3.75 million shares trade hands over the course of the day. It has outperformed by 29.50% the S&P500.

Camarda Financial Advisors Llc decreased its stake in Amgen Inc (AMGN) by 13.55% based on its latest 2016Q4 regulatory filing with the SEC.

WARNING: "Amgen Inc. (AMGN) Shares Sold by Boston Family Office LLC" was posted by TrueBlueTribune and is the property of of TrueBlueTribune. This indicates more upside for the $134.15 billion company.

About 141,290 shares traded. Amgen, Inc. (NASDAQ:AMGN) has risen 5.27% since September 12, 2016 and is uptrending. It has underperformed by 11.43% the S&P500.

Sell-side analyst recommendations point to a short term price target of $48.13 on the shares of Popular, Inc. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the stock. UBS Asset Management Americas Inc. increased its holdings in shares of Amgen by 3.1% in the first quarter.

Several analysts have released ratings on AMGN of late. The rating was maintained by Mizuho on Friday, July 14 with "Buy". (NASDAQ:AMGN). Bridges Inv Counsel reported 0.91% of its portfolio in Amgen, Inc. Finally, BMO Capital Markets reaffirmed a "buy" rating and issued a $198.00 price target (down previously from $200.00) on shares of Amgen in a research note on Monday, May 22nd. The stock has an average rating of "Buy" and a consensus price target of $186.04. The stock has "Market Perform" rating by Leerink Swann on Wednesday, March 23. The company was maintained on Tuesday, August 29 by Oppenheimer.

Investors sentiment decreased to 1.09 in Q4 2016. Its down 0.10, from 1.25 in 2016Q3. It worsened, as 98 investors sold AMGN shares while 488 reduced holdings. 111 funds opened positions while 527 raised stakes. 1,694,354 shares of the stock were exchanged. Tctc Ltd invested 0.3% in Amgen, Inc. (NASDAQ:AMGN) for 48.10M shares. Alpha Omega Wealth Management LLC now owns 625 shares of the medical research company's stock worth $103,000 after acquiring an additional 100 shares during the last quarter. Gemmer Asset Limited Liability Com invested 0.07% of its portfolio in Amgen, Inc. Plante Moran Finance Ltd Llc has 0.29% invested in Amgen, Inc. (NASDAQ:AMGN). Community Trust Investment Com has invested 0.03% in Amgen, Inc. (NASDAQ:AMGN). Highland Management Limited Company invested in 13,757 shares. Private Wealth Prtnrs Ltd Liability holds 77,400 shares or 0.99% of its portfolio. (NASDAQ:AMGN). Hsbc Public Limited holds 0.3% or 876,708 shares. Of Virginia Va invested in 58,306 shares. Americafirst Cap Llc invested in 0% or 1,959 shares.

American Assets Investment Management Llc increased Amgen (AMGN) stake by 50.74% reported in 2016Q4 SEC filing. Capital holds 2.68 million shares or 0.57% of its portfolio. It is positive, as 69 investors sold MET shares while 359 reduced holdings. 348,609 are owned by Grp Inc Inc. $451,164 worth of Amgen, Inc. More interesting news about Amgen, Inc.

Since May 24, 2017, it had 0 insider purchases, and 2 sales for $1.02 million activity. Blackrock Advsrs Llc invested in 2.49M shares or 0.37% of the stock.

Woodley Farra Manion Portfolio Management Inc, which manages about $607.27M and $737.42 million US Long portfolio, upped its stake in Procter And Gamble Co (NYSE:PG) by 4,432 shares to 323,545 shares, valued at $27.20 million in 2016Q4, according to the filing. It also reduced its holding in Chevron Corp New (NYSE:CVX) by 2,898 shares in the quarter, leaving it with 5,258 shares, and cut its stake in F5 Networks Inc (NASDAQ:FFIV).

Among 15 analysts covering Novartis Ag (NYSE:NVS), 5 have Buy rating, 2 Sell and 8 Hold. Therefore 60% are positive. Vical had 4 analyst reports since July 19, 2016 according to SRatingsIntel. The firm has "Outperform" rating by FBR Capital given on Thursday, May 25. The firm has "Hold" rating by Gabelli given on Friday, August 26. The rating was upgraded by Piper Jaffray to "Overweight" on Thursday, November 5. The rating was maintained by Argus Research with "Buy" on Wednesday, August 9. The company was maintained on Wednesday, September 30 by JP Morgan. The company was maintained on Thursday, July 20 by Cowen & Co. The company presently has a consensus rating of "Buy" and an average target price of $186.04. The company declared a dividend that was paid on Friday September 8th, 2017.

Other reports by Click Lancashire

Discuss This Article